COVID-19 Testing: More details
COVID-19 Resources: More details
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safel
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the design and development of innovative surgical technologies for robotic single access surgery, announced today that it has received payment f
VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it has commenced an underwritten public offering of its common
TBG & BCS announce shipment of their 6 MeV Compact/High Current Proton Cyclotron for Generation of Neutron Beams & Medical Isotope Production OTTAWA, Ontario & VANCOUVER, British Columbia & WASHINGTON & BEIJING--(BUSINESS WIRE)--#6MeV--TeamBest G
VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the pricing of its underwritten public offering of 9,160,000 common
SAN MATEO, Calif.--(BUSINESS WIRE)--Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the pricing of an upsized underwritten public offering of 4,074,0
BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (Anaergia) (TSX: ANRG) is pleased to announce it has signed a follow-up contract with Carbon Cycle North Carolina LLC (C2NC). Under the terms of this new agreement, the scope of Anaergia’s activities w
Furthers Alira Health’s Commitment to Empower Patients on their Healthcare Journey FRAMINGHAM, Mass.--(BUSINESS WIRE)--#healthcare--Alira Health (www.alirahealth.com), a global healthcare consulting and technology firm, announced that it has acquired S
First device will focus on preventing chemotherapy-induced peripheral neuropathy, a debilitating and painful side effect of cancer treatment. HOUSTON--(BUSINESS WIRE)--Eisana Corporation, a development stage medical device company dedicated to mitigating
OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intak
Sustainable Protein Food Systems: Meeting Future Needs
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.